David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 109,775 shares at $31.39 ($3.1M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Open-market sale of $3.1M OLMA by CH. DISCOV. & NON-CLIN Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,000 | $0 | 0.0% |
| 2 | $28.08 | 1,225 | $34K | 1.1% |
| 3 | $30.40 | 43,729 | $1.3M | 43.3% |
| 4 | $30.40 | 43,729 | $1.3M | 43.3% |
| 5 | $31.39 | 6,046 | $190K | 6.2% |
| 6 | $31.39 | 6,046 |
| $190K |
| 6.2% |
| Total | $27.99 avg | 109,775 | $3.1M | 100% |
| Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |
| OLMA | SELL | 2023-11-03 | $312K | — | Filing → |